SIMPSON TODD E Insider Trading
Get the latest insider transactions of SIMPSON TODD E. SIMPSON TODD E is VP, CFO, Treas. & Sec. in AmpliPhi Biosciences Corp ($APHB) and Chief Financial Officer in SEATTLE GENETICS INC /WA ($SGEN) and See Remarks in SEATTLE GENETICS INC /WA ($SGEN) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP). Discover the current value of SIMPSON TODD E shares.
Address: 1100 OLIVE WAY SUITE 100 SEATTLE 98101WA
SIMPSON TODD E is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| APHB | Armata Pharmaceuticals, Inc. | VP, CFO, Treas. & Sec. | 0 | 0.00 |
| NLTX | Neoleukin Therapeutics, Inc. | Director | 0 | 0.00 |
| SGEN | Seagen Inc. | See Remarks, Chief Financial Officer | 152,436 | 9,266,584.44 |
Insider Trading Transactions of SIMPSON TODD E
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | NLTX | Neoleukin Therapeutics, I ... | SIMPSON TODD E | Director | Option Exercise | 11.40 | 25,000 | 285,000 | 25,000 |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Offic ... | Buy | 26.10 | 33,669 | 878,761 | 152,436 |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Offic ... | Sell | 200.00 | 33,669 | 6,733,800 | 118,767 |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Offic ... | Buy | 45.30 | 1,104 | 50,011 | 119,871 |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 45.30 | 1,104 | 50,011 | 0 |
| Dec 18 2020 | SGEN | Seagen Inc. | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 26.10 | 33,669 | 878,761 | 0 |
| Sep 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 155.69 | 2,065 | 321,509 | 140,489 |
| Sep 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 155.69 | 2,122 | 330,383 | 138,367 |
| Sep 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 155.25 | 4,452 | 691,173 | 133,915 |
| Sep 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 155.74 | 5,480 | 853,455 | 128,435 |
| Sep 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 156.87 | 1,640 | 257,267 | 126,795 |
| Sep 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 157.82 | 50 | 7,891 | 126,745 |
| Sep 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 159.33 | 469 | 74,726 | 126,276 |
| Aug 20 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 158.17 | 9,262 | 1,464,959 | 142,554 |
| Aug 17 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 8,635 | 0 | 151,816 |
| Aug 17 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 161.82 | 636 | 102,918 | 636 |
| Aug 17 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 161.82 | 20,774 | 3,361,649 | 20,774 |
| Aug 17 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 8,635 | 0 | 151,816 |
| Aug 17 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 161.82 | 636 | 102,918 | 636 |
| Aug 17 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 161.82 | 20,774 | 3,361,649 | 20,774 |
| Aug 05 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 164.96 | 7,720 | 1,273,491 | 155,461 |
| Aug 05 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 166.10 | 10,375 | 1,723,288 | 145,086 |
| Aug 05 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 166.74 | 1,905 | 317,640 | 143,181 |
| Jul 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 165.86 | 1,300 | 215,618 | 173,454 |
| Jul 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 166.99 | 4,112 | 686,663 | 169,342 |
| Jul 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 167.66 | 5,012 | 840,312 | 164,330 |
| Jul 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 170.18 | 139 | 23,655 | 164,191 |
| Jul 02 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 171.39 | 1,010 | 173,104 | 163,181 |
| May 07 2020 | NLTX | Neoleukin Therapeutics, I ... | SIMPSON TODD E | Director | Option Exercise | 12.84 | 25,000 | 321,000 | 25,000 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 12.00 | 14,167 | 170,004 | 175,863 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 147.00 | 14,167 | 2,082,556 | 161,696 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 15.46 | 26,867 | 415,364 | 188,563 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 162.45 | 13,500 | 2,193,075 | 175,063 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 163.36 | 12,167 | 1,987,601 | 162,896 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 164.10 | 1,200 | 196,920 | 161,696 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 45.30 | 1,103 | 49,966 | 162,799 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 39.15 | 2,554 | 99,989 | 165,353 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 44.09 | 2,268 | 99,996 | 167,621 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 41.04 | 2,436 | 99,973 | 170,057 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 26.10 | 3,831 | 99,989 | 173,888 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 26.10 | 3,831 | 99,989 | 0 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 39.15 | 2,554 | 99,989 | 0 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 41.04 | 2,436 | 99,973 | 0 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 44.09 | 2,268 | 99,996 | 0 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 45.30 | 1,103 | 49,966 | 0 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 12.00 | 14,167 | 170,004 | 0 |
| May 06 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 15.46 | 26,867 | 415,364 | 0 |
| Apr 21 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 2,389 | 0 | 160,827 |
| Apr 21 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 1,439 | 0 | 162,266 |
| Apr 21 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 139.92 | 570 | 79,752 | 161,696 |
| Apr 21 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 2,389 | 0 | 160,827 |
| Apr 21 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 1,439 | 0 | 162,266 |
| Apr 21 2020 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 139.92 | 570 | 79,752 | 161,696 |
| Dec 23 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 871 | 0 | 158,438 |
| Oct 15 2019 | AQXP | Neoleukin Therapeutics, I ... | SIMPSON TODD E | Director | Option Exercise | 2.82 | 22,000 | 62,040 | 22,000 |
| Oct 15 2019 | AQXP | Neoleukin Therapeutics, I ... | SIMPSON TODD E | Director | Option Exercise | 2.82 | 22,000 | 62,040 | 22,000 |
| Oct 02 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 85.00 | 15,000 | 1,275,000 | 157,567 |
| Sep 04 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | See Remarks | Buy | 0.00 | 21,288 | 0 | 174,659 |
| Sep 04 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | See Remarks | Sell | 70.80 | 2,092 | 148,112 | 172,567 |
| Sep 04 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | See Remarks | Option Exercise | 72.64 | 1,333 | 96,829 | 1,333 |
| Sep 04 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | See Remarks | Option Exercise | 72.64 | 49,232 | 3,576,212 | 49,232 |
| Aug 30 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 73.21 | 5,909 | 432,624 | 153,371 |
| Aug 22 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 80.00 | 12,500 | 1,000,000 | 159,280 |
| Apr 09 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 78.00 | 2,063 | 160,914 | 182,217 |
| Apr 09 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 78.00 | 10,437 | 814,086 | 171,780 |
| Apr 09 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 78.00 | 2,063 | 160,914 | 182,217 |
| Apr 09 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 78.00 | 10,437 | 814,086 | 171,780 |
| Mar 06 2019 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 75.00 | 10,000 | 750,000 | 184,280 |
| Sep 04 2018 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 20,715 | 0 | 194,280 |
| Sep 04 2018 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 76.86 | 1,301 | 99,995 | 1,301 |
| Sep 04 2018 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 76.86 | 47,904 | 3,681,901 | 47,904 |
| Aug 29 2018 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 74.23 | 5,427 | 402,856 | 173,565 |
| Aug 29 2018 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 74.23 | 5,427 | 402,856 | 173,565 |
| May 09 2018 | AQXP | AQUINOX PHARMACEUTICALS, ... | SIMPSON TODD E | Director | Option Exercise | 13.10 | 15,000 | 196,500 | 15,000 |
| Mar 22 2018 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 34.20 | 10,526 | 359,989 | 10,526 |
| Nov 03 2017 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 60.90 | 38,851 | 2,366,026 | 179,526 |
| Nov 03 2017 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 61.59 | 534 | 32,889 | 178,992 |
| Sep 08 2017 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 52.00 | 9,638 | 501,176 | 218,377 |
| Aug 30 2017 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 47.89 | 4,937 | 236,455 | 228,015 |
| Aug 18 2017 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 23,000 | 0 | 232,952 |
| Aug 18 2017 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 46.37 | 2,156 | 99,974 | 2,156 |
| Aug 18 2017 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 46.37 | 55,344 | 2,566,301 | 55,344 |
| May 10 2017 | AQXP | AQUINOX PHARMACEUTICALS, ... | SIMPSON TODD E | Director | Option Exercise | 13.74 | 9,000 | 123,660 | 9,000 |
| Aug 30 2016 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 18,000 | 0 | 209,445 |
| Aug 30 2016 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 45.30 | 2,207 | 99,977 | 2,207 |
| Aug 30 2016 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 45.30 | 42,793 | 1,938,523 | 42,793 |
| Aug 22 2016 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 46.59 | 3,991 | 185,943 | 191,445 |
| May 11 2016 | AQXP | AQUINOX PHARMACEUTICALS, ... | SIMPSON TODD E | Director | Option Exercise | 7.73 | 7,500 | 57,975 | 7,500 |
| Oct 01 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 15.46 | 6,468 | 99,995 | 186,342 |
| Oct 01 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 12.00 | 8,333 | 99,996 | 194,675 |
| Oct 01 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 12.00 | 8,333 | 99,996 | 0 |
| Oct 01 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 15.46 | 6,468 | 99,995 | 0 |
| Aug 25 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Sell | 42.02 | 5,825 | 244,794 | 162,874 |
| Aug 25 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Buy | 0.00 | 17,000 | 0 | 179,874 |
| Aug 25 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 39.15 | 2,554 | 99,989 | 2,554 |
| Aug 25 2015 | SGEN | SEATTLE GENETICS INC /WA | SIMPSON TODD E | Chief Financial Offic ... | Option Exercise | 39.15 | 39,946 | 1,563,886 | 39,946 |
| Mar 16 2015 | AQXP | AQUINOX PHARMACEUTICALS, ... | SIMPSON TODD E | Director | Option Exercise | 12.03 | 5,000 | 60,150 | 5,000 |
| May 26 2005 | APHB | AmpliPhi Biosciences Corp | SIMPSON TODD E | VP, CFO, Treas. & Sec ... | Option Exercise | 0.91 | 75,000 | 68,250 | 75,000 |
| May 24 2004 | APHB | AmpliPhi Biosciences Corp | SIMPSON TODD E | VP, CFO, Treas. & Sec ... | Option Exercise | 1.31 | 150,000 | 196,500 | 150,000 |